KGN
文献支持

KGN

收藏
  • ¥2800
  • EK-Bioscience已认证
  • CA-Y1716
  • 2025年07月11日
    avatar
    品牌商
    11钻石会员
  • 企业认证

    点击 QQ 联系

  • 万千商家帮你免费找货

    0 人在求购买到急需产品
    • 详细信息
    • 文献和实验
    • 技术资料
    • 规格

      T25

    KGN/KGN细胞系/KGN细胞株/KGN人卵巢颗粒细胞

    Cell line name KGN

    Accession CVCL_0375

    Resource Identification Initiative To cite this cell line use: KGN (RRID:CVCL_0375)

    Comments Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).

    Part of: COSMIC cell lines project.

    Population: Japanese.

    Doubling time: 46.4 hours (PubMed=11145608).

    Microsatellite instability: Stable (MSS) (Sanger).

    Omics: Deep exome analysis.

    Omics: Deep quantitative proteome analysis.

    Omics: DNA methylation analysis.

    Omics: SNP array analysis.

    Omics: Transcriptome analysis by microarray.

    Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.

    PubMed=11145608; DOI=10.1210/endo.142.1.7862

    Nishi Y., Yanase T., Mu Y.-M., Oba K., Ichino I., Saito M., Nomura M., Mukasa C., Okabe T., Goto K., Takayanagi R., Kashimura Y., Haji M., Nawata H.

    Establishment and characterization of a steroidogenic human granulosa-like tumor cell line, KGN, that expresses functional follicle-stimulating hormone receptor.

    Endocrinology 142:437-445(2001)

     

    PubMed=15541573; DOI=10.1016/j.mce.2004.04.018

    Havelock J.C., Rainey W.E., Carr B.R.

    Ovarian granulosa cell lines.

    Mol. Cell. Endocrinol. 228:67-78(2004)

     

    PubMed=18980698; DOI=10.1186/1471-2407-8-319; PMCID=PMC2584659

    Imai M., Muraki M., Takamatsu K., Saito H., Seiki M., Takahashi Y.

    Spontaneous transformation of human granulosa cell tumours into an aggressive phenotype: a metastasis model cell line.

    BMC Cancer 8:319.1-319.10(2008)

     

    PubMed=19956657; DOI=10.1371/journal.pone.0007988; PMCID=PMC2777318

    Schrader K.A., Gorbatcheva B., Senz J., Heravi-Moussavi A., Melnyk N., Salamanca C.M., Maines-Bandiera S.L., Cooke S.L., Leung P.C.K., Brenton J.D., Gilks C.B., Monahan J.E., Huntsman D.G.

    The specificity of the FOXL2 c.402C>G somatic mutation: a survey of solid tumors.

    PLoS ONE 4:E7988-E7988(2009)

     

    PubMed=20098707; DOI=10.1371/journal.pone.0008789; PMCID=PMC2808356

    Benayoun B.A., Caburet S., Dipietromaria A., Georges A., D'Haene B., Pandaranayaka P.J.E., L'Hote D., Todeschini A.-L., Krishnaswamy S., Fellous M., De Baere E., Veitia R.A.

    Functional exploration of the adult ovarian granulosa cell tumor-associated somatic FOXL2 mutation p.Cys134Trp (c.402C>G).

    PLoS ONE 5:E8789-E8789(2010)

     

    PubMed=20164919; DOI=10.1038/nature08768; PMCID=PMC3145113

    Bignell G.R., Greenman C.D., Davies H.R., Butler A.P., Edkins S., Andrews J.M., Buck G., Chen L., Beare D., Latimer C., Widaa S., Hinton J., Fahey C., Fu B.-Y., Swamy S., Dalgliesh G.L., Teh B.T., Deloukas P., Yang F.-T., Campbell P.J., Futreal P.A., Stratton M.R.

    Signatures of mutation and selection in the cancer genome.

    Nature 463:893-898(2010)

     

    PubMed=27397505; DOI=10.1016/j.cell.2016.06.017; PMCID=PMC4967469

    Iorio F., Knijnenburg T.A., Vis D.J., Bignell G.R., Menden M.P., Schubert M., Aben N., Goncalves E., Barthorpe S., Lightfoot H., Cokelaer T., Greninger P., van Dyk E., Chang H., de Silva H., Heyn H., Deng X.-M., Egan R.K., Liu Q.-S., MirT., Mitropoulos X., Richardson L., Wang J.-H., Zhang T.-H., Moran S., Sayols S., Soleimani M., Tamborero D., Lopez-Bigas N., Ross-Macdonald P., Esteller M., Gray N.S., Haber D.A., Stratton M.R., Benes C.H., Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.

    A landscape of pharmacogenomic interactions in cancer.

    Cell 166:740-754(2016)

     

    PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747; PMCID=PMC6445675

    Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

    An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

    Cancer Res. 79:1263-1273(2019)

     

    PubMed=35839778; DOI=10.1016/j.ccell.2022.06.010; PMCID=PMC9387775

    Goncalves E., Poulos R.C., Cai Z.-X., Barthorpe S., Manda S.S., Lucas N., Beck A., Bucio-Noble D., Dausmann M., Hall C., Hecker M., Koh J., Lightfoot H., Mahboob S., Mali I., Morris J., Richardson L., Seneviratne A.J., Shepherd R., Sykes E., Thomas F., Valentini S., Williams S.G., Wu Y.-X., Xavier D., MacKenzie K.L., Hains P.G., Tully B., Robinson P.J., Zhong Q., Garnett M.J., Reddel R.R.

    Pan-cancer proteomic map of 949 human cell lines.

    Cancer Cell 40:835-849.e8(2022)

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    该产品被引用文献

    *发表【中文论文】请标注:由上海酶研生物科技有限公司提供;

    *发表【英文论文】请标注:From Shanghai EK-Bioscience Biotechnology Co., Ltd.

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥1600
    上海盖宁生物科技有限公司
    2025年12月11日询价
    ¥2800
    上海酶研生物科技有限公司
    2025年07月11日询价
    ¥1600
    上海匹拓生物科技有限公司
    2025年12月05日询价
    ¥900
    安元生物科技(南京)有限公司
    2025年07月16日询价
    ¥1800
    博辉生物科技(广州)有限公司
    2025年11月28日询价
    文献支持
    KGN
    ¥2800